Market Size (2025)
$80.55M
Vertical: CNMBase Year: 2025
Market Size (2025)
$80.55M
Projected (2032)
$127.22M
CAGR (2022–2032)
6.8%
Key Players
10+
Market Overview
The Global Pyrethroid Intermediates Market was valued at USD 80.55 Million in 2025 and is projected to reach USD 127.22 Million by 2032, expanding at a CAGR of 6.73% during the forecast period 2026–2032. Over 2025–2032 the market is expected to add USD 46.66 Million in absolute value. The market stood at USD 65.98 Million in 2022 and has grown steadily through the historic period, reaching USD 75.39 Million in 2024.
Pyrethroid intermediates are the acid-moiety and alcohol-moiety building blocks from which synthetic pyrethroid insecticides are manufactured. The most commercially important intermediates include DV acid chloride (cypermethric or permethric acid chloride), lambda-cyhalothric acid and its acid chloride, chrysanthemic acid derivatives, 3-phenoxybenzaldehyde (MPBD) and 3-phenoxybenzyl alcohol. Demand for these intermediates is driven directly by production of pyrethroid technical-grade active ingredients such as cypermethrin, lambda-cyhalothrin, permethrin, deltamethrin and bifenthrin, which are used in agriculture, public health vector control, animal health and household insecticides.
Production is heavily concentrated in Asia. China and India together host the majority of global manufacturing capacity for both the intermediates and the pyrethroid technicals into which they are converted, and much of the intermediate volume is consumed captively by backward-integrated technical producers. Growth through 2032 is supported by sustained crop-protection demand in Asia Pacific and Latin America, the shift towards isomer-enriched, high-efficacy pyrethroids, and ongoing capacity investment by integrated producers in both countries.
Key Findings
By downstream product: Cypermethrin is the largest segment, accounting for 35.0% of the market in 2025 (USD 28.19 Million), while Lambda-Cyhalothrin is the fastest-growing segment with a CAGR of 8.04% over 2026–2032.
By purity: The 98% & Above segment holds the largest share at 80.0% in 2025 (USD 64.44 Million) and is also the fastest-growing purity segment, with a CAGR of 7.05%.
By region: Asia Pacific is the leading region with 78.0% of global value in 2025 (USD 62.83 Million), while Middle East & Africa is the fastest-growing region with a CAGR of 7.93%.
By country: China is the leading country market, valued at USD 28.90 Million in 2025, equivalent to 35.9% of the global market. Saudi Arabia is the fastest-growing country, with a CAGR of 8.45% over 2026–2032.
Absolute growth: Asia Pacific is expected to contribute USD 36.70 Million of the USD 46.66 Million incremental market value between 2025 and 2032.
Segmentation Summary
The market is analysed by downstream product (Cypermethrin, Lambda-Cyhalothrin, Permethrin and Others), by purity (98% & Above and Below 98%), and by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level analysis within each region. Intermediates destined for Cypermethrin, valued at USD 28.19 Million in 2025, form the largest product segment, reflecting cypermethrin's position as one of the highest-volume generic insecticides worldwide. Lambda-Cyhalothrin intermediates, at USD 20.14 Million in 2025, are expected to grow fastest at 8.04%, as growers continue to move toward lower-dose, isomer-enriched pyrethroids. In terms of purity, high-purity intermediates (98% & Above) dominate with 80.0% of the market, since modern technical synthesis and international specifications increasingly require tight impurity and isomer control.
Competitive Landscape Summary
The competitive landscape is moderately consolidated and geographically concentrated in China and India. Leading participants are largely backward-integrated pyrethroid technical manufacturers that produce key intermediates such as DV acid chloride, lambda-cyhalothric acid and MPBD for captive use and, in several cases, for merchant sale. Key companies include Jiangsu Yangnong Chemical Co., Ltd., Gharda Chemicals Ltd., Tagros Chemicals India Pvt. Ltd., Hemani Industries Ltd., Heranba Industries Ltd., Meghmani Organics Ltd., Bharat Rasayan Ltd., Sumitomo Chemical Co., Ltd., Guangdong Liwei Chemical Industry Co., Ltd. and Weifang Maoyuan Biotechnology Co., Ltd. Competition is driven by cost position, degree of integration, process technology for isomer-specific products, environmental compliance and access to export registrations. Since 2022, competitive activity has centred on capacity expansion, new greenfield sites and selective acquisitions, alongside trade-remedy measures that have reshaped India–China trade flows in cypermethrin and MPBD.
Challenges and Opportunities
Key challenges include tightening environmental, health and safety requirements for chemical manufacturing in China and India, regulatory scrutiny of pyrethroids in the European Union and the United States because of their aquatic toxicity, the spread of pyrethroid resistance in key insect pests and disease vectors, and anti-dumping duties that restrict cross-border trade in specific intermediates and technicals. Volatile feedstock and energy costs, together with periodic destocking cycles in the agrochemical channel, add pressure on producer margins.
Opportunities lie in supply-chain diversification by global agrochemical companies, rising demand for high-purity and isomer-specific intermediates, cleaner and more efficient process technologies, and expanding crop-protection and vector-control demand in Latin America, the Middle East and Africa, where the market is projected to grow faster than the global average.
Future Outlook
The market is expected to expand from USD 86.06 Million in 2026 to USD 127.22 Million in 2032. Asia Pacific will remain the production and consumption centre of the industry, rising from USD 62.83 Million in 2025 to USD 99.54 Million in 2032. Product mix is expected to tilt gradually toward Lambda-Cyhalothrin, whose share rises from 25.0% in 2025 to 27.3% in 2032, and toward other newer pyrethroids, whose share rises from 25.0% to 25.6%, while Cypermethrin's share declines from 35.0% in 2025 to 32.7% in 2032 despite continued absolute growth. Integrated producers with captive intermediate capacity, strong environmental performance and broad registration portfolios are best positioned to benefit.
The Pyrethroid Intermediates Market market is projected to grow at a CAGR of 6.8% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Synthetic pyrethroids are esters formed by combining a substituted cyclopropanecarboxylic acid (the "acid moiety") with an aromatic alcohol (the "alcohol moiety"). Pyrethroid intermediates are the chemical compounds that supply these two moieties, together with their immediate precursors, and that are converted by esterification and related steps into pyrethroid technical-grade active ingredients.
For the purpose of this study, the market includes:
Acid-moiety intermediates: DV acid and DV acid chloride (3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid and its chloride, also known as cypermethric or permethric acid chloride, CMAC), including high-cis and high-trans grades; lambda-cyhalothric acid and its acid chloride; chrysanthemic acid and its derivatives; and other cyclopropane acid intermediates used for deltamethrin, bifenthrin and related actives.
Alcohol-moiety intermediates: 3-phenoxybenzaldehyde (m-phenoxybenzaldehyde, MPBD), 3-phenoxybenzyl alcohol (MPBAL), cyanohydrin derivatives, and other aromatic alcohols such as 2-methyl-3-biphenylmethanol used in bifenthrin.
Key precursors that are produced specifically for pyrethroid synthesis, such as cyclopropane ester precursors.
Intermediates supplied on the merchant market and intermediates produced for captive consumption, valued at intermediate level.
The market excludes:
Finished pyrethroid technical-grade active ingredients and their formulated products.
Natural pyrethrins and pyrethrum extract derived from Chrysanthemum cinerariifolium.
Synergists such as piperonyl butoxide and general-purpose commodity chemicals (for example chlorobenzene, m-cresol or thionyl chloride) that are not manufactured specifically for pyrethroid synthesis.
Scope of the Study
The study covers the global market for pyrethroid intermediates, segmented as follows:
By Downstream Product: Cypermethrin, Lambda-Cyhalothrin, Permethrin and Others.
By Purity: 98% & Above and Below 98%.
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); and Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: historic years 2022–2024, base year 2025 and forecast years 2026–2032, with CAGR stated for 2026–2032.
Unit: all market values are presented in USD Million.
Research Objectives
To estimate and forecast the size of the global pyrethroid intermediates market in value terms from 2022 to 2032.
To analyse the market by downstream product and quantify the demand for intermediates linked to Cypermethrin, Lambda-Cyhalothrin, Permethrin and other pyrethroids.
To assess the market by purity grade and evaluate the shift toward high-purity (98% & Above) intermediates.
To analyse regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges influencing intermediate demand and supply, including environmental regulation and trade remedies.
To map the value chain from basic feedstocks through intermediate synthesis to pyrethroid technicals, formulations and end users.
To evaluate the regulatory landscape governing pyrethroids and their manufacture in major regions.
To profile the competitive environment, including positioning, capability ratings and strategic developments of leading manufacturers since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process. It begins with defining the market boundary and segmentation, followed by extensive secondary research to build an understanding of pyrethroid chemistry, production capacity, trade flows and regulation. Primary research with participants across the supply and demand sides is then used to validate assumptions, refine estimates and gather qualitative insight. Market size is estimated using both top-down and bottom-up approaches and reconciled through data triangulation, after which forecasts are developed for 2026–2032 using a factor-based model.
Stage 1 – Market definition and scoping: identification of intermediates, downstream pyrethroids, purity grades and geographic coverage.
Stage 2 – Secondary research: collection of data from public, regulatory, corporate and paid sources.
Stage 3 – Primary research: interviews with industry participants to validate and enrich findings.
Stage 4 – Market estimation and forecasting: top-down and bottom-up modelling, triangulation and scenario checks.
Stage 5 – Quality review: internal consistency checks across segments, regions and countries before finalisation.
Secondary Research
Secondary research drew on sources relevant to the agrochemical and fine-chemicals industries, including:
Industry associations: CropLife International and regional CropLife bodies, the Crop Care Federation of India, the Pesticides Manufacturers & Formulators Association of India, the China Crop Protection Industry Association and the European Crop Protection Association.
Government and regulatory bodies: the U.S. Environmental Protection Agency, the European Commission (EU Pesticides Database), the European Chemicals Agency, the European Food Safety Authority, India's Central Insecticides Board & Registration Committee, China's Institute for the Control of Agrochemicals, Ministry of Agriculture and Rural Affairs (ICAMA), and Brazil's Ministry of Agriculture and Livestock (MAPA).
Trade and customs data: national customs statistics, trade-remedy notices issued by China's Ministry of Commerce and India's Directorate General of Trade Remedies, and international trade databases for the relevant HS codes.
Company filings: annual reports, stock exchange disclosures, investor presentations, credit rating rationales, environmental clearance documents and draft offer documents of listed and unlisted producers.
Trade journals and technical literature: agrochemical trade publications, chemical industry news services, patents and peer-reviewed literature on pyrethroid synthesis and resistance.
Paid databases: company financial databases, agrochemical market intelligence services and pesticide registration databases.
Primary Research
Primary research was conducted through in-depth interviews and structured discussions with participants on both the supply and demand sides of the value chain. The objectives were to validate market size and segment splits, understand capacity utilisation and pricing dynamics, assess the outlook for each downstream pyrethroid, and gather views on regulation and trade measures.
Supply side: production, business development and technical managers at intermediate and pyrethroid technical manufacturers; raw material suppliers; and process technology specialists.
Demand side: procurement and supply-chain managers at pyrethroid technical producers and formulators, distributors and traders of agrochemical intermediates, and specialists in public health and household insecticide supply.
Industry experts: regulatory consultants, agronomists, entomologists and independent industry analysts.
Market Size Estimation
Top-down approach: The global market for pyrethroid technical-grade active ingredients was estimated and broken down by downstream product. Intermediate demand for each product was derived using stoichiometric consumption norms (quantity of acid and alcohol moiety intermediates per tonne of technical), adjusted for process yields, and multiplied by representative intermediate prices to obtain value.
Bottom-up approach: Production capacities, utilisation rates and captive versus merchant volumes of individual intermediate manufacturers were compiled by country and aggregated. Country-level consumption was derived from production, adjusted for imports and exports of intermediates and technicals, and then summed to regional and global totals.
Data triangulation: The results of the two approaches were compared and reconciled. Where differences occurred, estimates were re-examined against trade data, company disclosures and primary interview inputs until segment, regional and country estimates were mutually consistent.
Forecasting Methodology
Forecasts for 2026–2032 were developed using a factor-based approach that links intermediate demand to downstream pyrethroid demand. Factors considered include:
Crop area, pest pressure and insecticide use intensity in major agricultural markets.
Product life-cycle trends, including the shift from conventional to isomer-enriched pyrethroids.
Public health programmes for vector control and growth in household insecticide consumption.
Announced capacity additions, plant closures and backward-integration projects.
Regulatory decisions, registration renewals and trade-remedy measures.
Price trends for intermediates and key feedstocks, and macroeconomic indicators.
Each factor was assessed for direction and strength of impact over the short, medium and long term, and the resulting growth rates were applied to base-year values. The CAGR for each segment is calculated over 2026–2032.
Assumptions and Limitations
Market values are expressed in nominal USD; local-currency data were converted using annual average exchange rates.
Captive intermediate consumption is valued at representative merchant-market prices to allow comparability across integrated and non-integrated producers.
Forecasts assume no major disruption to global trade beyond measures already in force, and no withdrawal of the principal pyrethroids from key markets within the forecast period.
The regulatory environment is assumed to evolve along currently announced timelines.
Private companies disclose limited operating data; for these, estimates rely on capacity information, regulatory filings and primary inputs.
Values are rounded to two decimal places, so minor differences may arise in totals.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Pyrethroid Intermediates Market is moderately consolidated and concentrated geographically in China and India. A relatively small number of large, backward-integrated pyrethroid producers account for a substantial share of intermediate output, alongside a wider base of specialist intermediate manufacturers and smaller producers. Much of the volume of key intermediates such as DV acid chloride, lambda-cyhalothric acid and 3-phenoxybenzaldehyde is consumed captively in pyrethroid technical production, with surplus sold on the merchant market domestically and for export.
Competition is based on production cost, integration depth, process technology for isomer-specific products, product quality, environmental compliance and access to registrations in export markets. The industry is shaped by environmental enforcement in China, which has favoured larger, compliant producers, and by trade remedies, including China's anti-dumping duties on Indian MPBD and cypermethrin, which influence competitive dynamics between Chinese and Indian suppliers. Since 2022, companies have pursued capacity expansions, new greenfield sites, overseas subsidiaries and selective acquisitions to strengthen their positions.
Key Player Positioning
Leaders: Jiangsu Yangnong Chemical Co., Ltd. is China's largest pyrethroid producer, with a comprehensive pyrethroid portfolio, self-supplied key intermediates and reported revenue of CNY 11.87 billion in 2025; it is controlled by the Sinochem/Syngenta Group. Gharda Chemicals Ltd., which reported revenue of INR 3,619 crore in FY2024-25, manufactures cypermethric acid chloride in high-cis and low-cis grades and is integrated into pyrethroid technicals. Tagros Chemicals India Pvt. Ltd. is a highly backward-integrated, export-led pyrethroid producer that has manufactured DV acid chloride since 1993. Hemani Industries Ltd. is a leading producer of MPBD and CMAC and a major manufacturer of cypermethrin, alpha-cypermethrin and permethrin.
Challengers: Heranba Industries Ltd. operates across the pyrethroid value chain, producing CMAC, MPBD and pyrethroid technicals, and has expanded capacity at Sarigam. Meghmani Organics Ltd., with FY2025-26 standalone revenue from operations of INR 2,091.8 crore, produces CMAC, MPB and m-phenoxybenzyl alcohol and a broad range of pyrethroid technicals, and has expanded bifenthrin capacity. Bharat Rasayan Ltd. holds a strong position in lambda-cyhalothrin technical and MPB. Guangdong Liwei Chemical Industry Co., Ltd. is a significant Chinese producer of lambda-cyhalothrin, bifenthrin and cypermethrin.
Niche players: Sumitomo Chemical Co., Ltd., with sales revenue of JPY 2,328.5 billion in FY2025 (ended March 2026), is an originator of many household and public health pyrethroids such as d-phenothrin, prallethrin, imiprothrin and metofluthrin and focuses on differentiated, proprietary actives. Weifang Maoyuan Biotechnology Co., Ltd. is a Chinese specialist producer of 3-phenoxybenzaldehyde.
Bargaining Power of Suppliers – Medium
Most basic feedstocks are commodity chemicals available from multiple sources, limiting supplier leverage.
Certain inputs, such as sodium cyanide and controlled chlorinated feedstocks, are subject to regulatory and logistics constraints that give specialised suppliers some pricing power.
Energy and solvent costs are volatile and largely outside producers' control.
Bargaining Power of Buyers – Medium to High
Buyers are mainly pyrethroid technical producers and multinational crop-protection companies with significant purchasing scale and technical expertise.
Many large buyers are backward integrated and can switch between captive and merchant supply.
Long-term qualification of suppliers and specification requirements moderate switching, partly offsetting buyer power.
Threat of New Entrants – Low to Medium
Multi-step synthesis, isomer control and handling of hazardous chemistry require process know-how and experienced personnel.
Environmental clearances, effluent treatment infrastructure and chemical park access involve high capital costs and long lead times.
Established producers benefit from scale, integration and existing customer qualifications.
Threat of Substitutes – Medium
Within pyrethroid synthesis, alternative routes exist but key intermediates such as DV acid chloride and MPBD have few practical substitutes.
At the end-use level, newer insecticide classes and biologicals compete with pyrethroids, particularly in developed markets and high-value crops.
The low cost and broad spectrum of pyrethroids limit substitution in price-sensitive markets.
Competitive Rivalry – High
Numerous Chinese and Indian producers compete in largely generic, specification-driven products.
Price competition intensifies during channel destocking and capacity additions.
Trade remedies, registrations and integration create differentiated competitive positions between producers.
Bargaining power of suppliers: Medium; Commodity feedstocks; some specialised and regulated inputs.
Bargaining power of buyers: Medium to High; Large, integrated buyers; specification-based qualification.
Threat of new entrants: Low to Medium; Technology, environmental clearances and capital intensity.
Threat of substitutes: Medium; Few substitutes for intermediates; end-use competition from newer chemistries.
Competitive rivalry: High; Many generic producers in China and India; price-driven competition.
Market estimates by geography (2032)
InsightAsia Pacific leads with $99.54M by 2032, while Middle East & Africa is projected to grow fastest at a 8.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $4.04M | $5.42M | $7.26M | 6.0% | 6% |
| Europe | $5.46M | $7.18M | $9.44M | 5.6% | 7% |
| Asia Pacific | $51.40M | $71.76M | $99.54M | 6.8% | 78% |
| Latin America | $3.81M | $5.65M | $8.22M | 8.0% | 6% |
| Middle East & Africa | $1.27M | $1.89M | $2.76M | 8.1% | 2% |
| Total | $65.98M | $91.91M | $127.22M | 6.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$127.22M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Cypermethrin | $41.59M | 5.7% | 33% |
| Lambda-Cyhalothrin | $34.74M | 8.2% | 27% |
| Others | $32.54M | 7.1% | 26% |
| Permethrin | $18.34M | 6.2% | 14% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Pyrethroid Intermediates Market covering market dynamics, competitive landscape, and strategic outlook.
The Pyrethroid Intermediates Market market is projected to reach $127.22M by 2032, growing at 6.8% CAGR. The Cypermethrin segment holds the largest share.
The Global Pyrethroid Intermediates Market is shaped by the demand for pyrethroid insecticides in agriculture, public health and household use, and by the structure of chemical manufacturing in China and India. Demand-side factors such as crop protection needs, the move to isomer-enriched actives and vector-control programmes interact with supply-side factors including environmental regulation, feedstock costs, capacity investment and trade measures. This chapter assesses these factors and their expected impact over the forecast period. The impact scores presented in the growth factor analysis are analyst assessments based on secondary research and primary interviews, rated on a scale of 1 (low impact) to 10 (high impact).
Growing Demand for Isomer-Enriched Pyrethroids such as Lambda-Cyhalothrin
Growers and formulators are moving from conventional racemic pyrethroids toward isomer-enriched actives such as lambda-cyhalothrin, alpha-cypermethrin, beta-cypermethrin and beta-cyfluthrin, which deliver equivalent or better efficacy at lower application rates. Lambda-cyhalothrin in particular is widely used on soybean, corn, cotton, rice and vegetables, and is a common partner in mixtures with neonicotinoids and diamides. This shift raises demand for the specific acid intermediates (lambda-cyhalothric acid and its acid chloride) and for high-purity alcohol intermediates such as MPBD. It is reflected in the data: Lambda-Cyhalothrin intermediates are the fastest-growing downstream product segment, rising from USD 20.14 Million in 2025 to USD 34.74 Million in 2032 at a CAGR of 8.04%. Producers have responded with capacity commitments: Jiangsu Yangnong's northern base at Huludao, for which an environmental impact assessment was published in October 2023, includes lambda-cyhalothrin among its technicals together with 7,000 tonnes per year of pesticide intermediates capacity.
Capacity Expansion and Backward Integration in India and China
Leading pyrethroid technical producers in China and India continue to invest in integrated capacity that covers intermediates, technicals and, increasingly, formulations. In India, Heranba Industries began commercial production at Phase I of its Sarigam site in the second quarter of FY2024-25 and at Phase II, with capacity of up to 9,000 tonnes per annum, in June 2025. Meghmani Organics raised its bifenthrin technical capacity to 5,000 tonnes per annum in October 2025, Gharda Chemicals committed INR 600 crore to a greenfield facility at Dahej in September 2023, and Tagros Chemicals received environmental clearance in March 2023 to expand technicals and intermediates at Cuddalore. In China, Jiangsu Yangnong's Huludao base, with a planned investment of CNY 4.238 billion, entered Phase 1 commissioning in 2025. Because pyrethroid technical producers secure cost and quality advantages by making their own intermediates, each of these expansions directly increases the demand for, and production of, pyrethroid intermediates.
Sustained Use of Pyrethroids in Public Health and Household Insecticides
Pyrethroids remain the backbone of many vector-control interventions because of their rapid knock-down effect and low mammalian toxicity at use rates. Permethrin, deltamethrin and alpha-cypermethrin are used in long-lasting insecticidal nets, indoor residual spraying, space spraying and treated clothing, while household products rely on pyrethroids such as prallethrin, transfluthrin, d-phenothrin and tetramethrin. Even newer dual-active-ingredient nets, introduced to manage pyrethroid resistance in malaria vectors, continue to contain a pyrethroid component. Dengue, malaria and other vector-borne diseases remain a major burden across Asia, Africa and Latin America, and urbanisation and changing climatic patterns are widening the geographic range of disease-carrying mosquitoes. This provides a steady, non-agricultural demand base for permethrin intermediates and for the intermediates grouped under Others, which together accounted for USD 12.08 Million and USD 20.14 Million, respectively, in 2025.
Agricultural Intensification in Asia Pacific and Latin America
Rising food demand, limited arable land and increasing pest pressure are driving greater use of crop-protection products in emerging agricultural economies. Pyrethroids are among the most cost-effective broad-spectrum insecticides available and are widely used by smallholders in India and Southeast Asia and in large-scale soybean, corn, cotton and sugarcane production in Brazil and Argentina. In Brazil, Law No. 14,785/2023 introduced statutory deadlines for pesticide registration, which is expected to speed approval of generic formulations based on established pyrethroids. Latin America is projected to be one of the fastest-growing regions for pyrethroid intermediates, expanding at a CAGR of 7.82% from USD 4.83 Million in 2025 to USD 8.22 Million in 2032, while Asia Pacific is expected to add USD 36.70 Million in absolute value over the same period.
Supply-Chain Diversification and Export Growth
Multinational crop-protection companies have sought to diversify sourcing of intermediates and technicals away from single-country dependence. Indian manufacturers with integrated intermediate capacity, international registrations and compliance with FAO/WHO specifications are well placed to capture this demand. Trade measures are also redirecting flows: China's anti-dumping duties on MPBD from India, extended in 2024, and on cypermethrin from India, imposed in May 2025, encourage Indian producers to focus on Latin America, Africa, the Middle East and other markets, while creating openings for third-country suppliers.
High-Purity and Isomer-Specific Intermediates
The move to isomer-enriched pyrethroids and tighter international specifications increases demand for high-cis and high-trans DV acid chloride, enantiomerically enriched lambda-cyhalothric acid and high-purity MPBD. The 98% & Above segment is projected to grow from USD 64.44 Million in 2025 to USD 103.98 Million in 2032 at a CAGR of 7.05%. Producers that invest in stereoselective synthesis, continuous-flow processing, solvent recovery and waste minimisation can capture premium pricing while reducing environmental footprint.
Expanding Demand in Latin America, the Middle East and Africa
Middle East & Africa is the fastest-growing region, projected to rise from USD 1.61 Million in 2025 to USD 2.76 Million in 2032 at a CAGR of 7.93%, supported by agricultural development and vector-control programmes. Latin America, driven by Brazil, is projected to grow at 7.82%. Suppliers that establish local registrations, distribution partnerships and, in some cases, regional formulation or trading hubs, such as Heranba Industries' planned UAE subsidiary approved in January 2026, can strengthen access to these markets.
Regulatory Scrutiny of Pyrethroids in Developed Markets
Pyrethroids are highly toxic to fish and aquatic invertebrates, and regulators in developed markets have imposed restrictions to limit environmental exposure. In the European Union, cypermethrin's approval was renewed in 2021 as a candidate for substitution, which requires comparative assessment against safer alternatives at product authorisation, and permethrin is not approved for plant protection use. In the United States, the Environmental Protection Agency's 2020 interim registration review decisions for pyrethroids introduced mitigation measures such as wider vegetative filter strips and reduced perimeter spray bands. These measures constrain volume growth in North America and Europe, which are projected to grow at 6.00% and 5.62%, respectively, below the global average of 6.73%.
Environmental Compliance Costs and Feedstock Volatility
The synthesis of pyrethroid intermediates involves chlorinated compounds, cyanide chemistry and multiple reaction steps that generate effluent and hazardous waste. Stricter environmental enforcement in China, intensified after the March 2019 explosion at the Chenjiagang chemical park in Xiangshui, Jiangsu, led to the closure of several intermediate plants and tightened supply. In India, new pesticide and pesticide-intermediate units require prior environmental clearance under the Environment Impact Assessment Notification, 2006. Compliance raises capital and operating costs and lengthens project timelines. Prices of feedstocks, solvents and energy are also volatile, and periodic destocking in the agrochemical channel, as seen in 2023 and 2024, can compress intermediate prices and margins.
Insect Resistance and Competition from Newer Chemistries
Decades of intensive use have produced widespread pyrethroid resistance in important agricultural pests and in malaria and dengue vectors. In agriculture, newer insecticide classes such as diamides, as well as biological controls, compete for spray programmes, particularly in high-value crops. In vector control, resistance has prompted a move to nets and spray products that combine or replace pyrethroids with other active ingredients. These trends limit volume growth for older pyrethroids, as reflected in the below-average CAGR of 5.72% for Cypermethrin intermediates.
Trade Remedies Reshaping India–China Flows
Trade remedies have become a defining feature of the pyrethroid supply chain. China has applied anti-dumping duties on 3-phenoxybenzaldehyde imported from India since 2018 and extended them in June 2024 after an expiry review. In May 2025, China imposed final anti-dumping duties for five years on cypermethrin from India, with company-specific rates ranging from 48.4% to 166.2%. These measures protect Chinese intermediate producers in their home market and encourage Indian producers to diversify export destinations.
Consolidation of Chinese Intermediate Supply
Environmental inspections and chemical park rationalisation in China since 2019 have led to closures of smaller intermediate units and concentrated supply among larger, integrated producers. Jiangsu Yangnong, which self-supplies key intermediates including lambda-cyhalothric acid and MPBD, is building additional intermediate capacity at its Huludao base. This trend favours scale, integration and compliance capability.
Price Cycles and Channel Destocking
The agrochemical industry experienced high prices and inventory building in 2021–2022, followed by significant destocking and falling generic active ingredient prices during 2023 and 2024. Intermediate producers, positioned upstream, felt these swings in volumes and realisations. Market participants are increasingly focused on cost optimisation, capacity utilisation and product diversification to manage cyclicality.
Sustainability and Regulatory Modernisation
Regulators are modernising pesticide frameworks: India released a draft Pesticides Management Bill, 2025 in January 2026 to replace the Insecticides Act, 1968, and Brazil's Law No. 14,785/2023 replaced its 1989 pesticide law. In parallel, customers increasingly expect suppliers to demonstrate responsible manufacturing, effluent treatment and traceability. Manufacturers must balance these requirements against cost pressure, making process innovation a key competitive challenge.
The pyrethroid intermediates value chain links basic and specialty chemicals to finished insecticide products used in agriculture, public health and households. It consists of four principal stages:
Value addition is highest at the intermediate and technical stages, where process know-how, yield, isomer control and environmental compliance determine cost position. Integration across the intermediate and technical stages is common among leading producers, which reduces dependence on merchant supply and improves margin capture.
Mar 2022: Hemani Industries Ltd.; Expansion; Filed a draft red herring prospectus for an INR 2,000 crore IPO, with proceeds earmarked partly for capacity expansion at its Saykha subsidiary.
Oct 2022: Meghmani Organics Ltd.; Launch; Commenced commercial production of cyfluthrin and spiromesifen technical at Dahej, with initial combined capacity of 500 MT per annum.
Nov 2022: Heranba Industries Ltd.; Expansion; Announced additional capital expenditure of INR 100 crore for H2 FY2022-23 at its Sarigam site, where Phase I covers pyrethroids and other insecticides.
Mar 2023: Tagros Chemicals India Pvt. Ltd.; Expansion; Received environmental clearance from the Ministry of Environment, Forest and Climate Change to expand pesticide technical and intermediate production at SIPCOT, Cuddalore.
Mar 2023: Jiangsu Yangnong Chemical Co., Ltd.; Expansion; Established subsidiary Liaoning Youchuang Plant Protection in Huludao as its northern production base.
Sep 2023: Gharda Chemicals Ltd.; Expansion; Committed INR 600 crore to a greenfield manufacturing facility at Payal Industrial Park, Dahej, Gujarat.
Sep 2023: Bharat Rasayan Ltd.; Partnership; Joint venture Nissan Bharat Rasayan, with Nissan Chemical, began commercial supply from its Saykha plant.
Oct 2023: Jiangsu Yangnong Chemical Co., Ltd.; Expansion; Published the environmental impact assessment for the Huludao base: CNY 4.238 billion investment for 15,650 t/yr of technicals, including lambda-cyhalothrin, and 7,000 t/yr of pesticide intermediates.
Feb 2024: Bharat Rasayan Ltd.; Expansion; Restarted Block D at its Dahej facility, restoring full capacity.
Jul–Sep 2024: Heranba Industries Ltd.; Expansion; Started commercial production at Phase I of its Sarigam facility.
Jun 2025: Heranba Industries Ltd.; Expansion; Subsidiary Heranba Organics began commercial production at Sarigam Phase II, with capacity of up to 9,000 MTPA of insecticides and fungicides.
Aug 2025: Jiangsu Yangnong Chemical Co., Ltd.; Expansion; Phase 1 of the Huludao (Liaoning Youchuang) base entered commissioning and ramp-up, with commissioned products reaching design capacity.
Oct 2025: Meghmani Organics Ltd.; Expansion; Increased bifenthrin technical capacity to 5,000 MT per annum, targeting demand in Brazil, Mexico and Argentina.
Jan 2026: Tagros Chemicals India Pvt. Ltd.; Acquisition; Agreed, through its subsidiary Arqivo, to acquire Bayer's flubendiamide business in markets outside India.
Jan 2026: Heranba Industries Ltd.; Expansion; Board approved incorporation of a subsidiary in the UAE for manufacturing and trading of agrochemicals.
Aug 2026: Jiangsu Yangnong Chemical Co., Ltd.; Expansion; Reported that the second stage of Phase 1 at the Huludao base was in trial production and that Phase 2 had been submitted for approval.
Political
Trade remedies, such as China's anti-dumping duties on Indian MPBD and cypermethrin, directly influence cross-border trade in intermediates and technicals.
Government policies promoting domestic chemical manufacturing in India support investment in integrated agrochemical capacity.
Food security priorities in emerging economies sustain policy support for crop-protection use.
Economic
Agricultural commodity prices and farm incomes influence insecticide demand and, in turn, intermediate demand.
Volatile feedstock, energy and freight costs affect producer margins.
Channel inventory cycles cause swings in volumes and prices of generic actives and intermediates.
Social
Public concern over pesticide residues and environmental impact is driving demand for lower-dose, more targeted products.
Vector-borne disease burden supports public health use of pyrethroids.
Urbanisation is increasing demand for household and structural pest control products.
Technological
Stereoselective synthesis and isomer separation enable production of high-value, isomer-enriched pyrethroids.
Continuous-flow processing, solvent recovery and catalytic routes can improve yields and reduce waste.
Formulation innovations, such as capsule suspensions and long-lasting net technologies, extend pyrethroid use.
Environmental
High aquatic toxicity of pyrethroids leads to use restrictions and buffer requirements in developed markets.
Effluent treatment and hazardous waste management are major cost and compliance issues for intermediate plants.
Climate change is altering pest and vector distribution, influencing demand patterns.
Legal
Registration renewals, candidate-for-substitution status and data requirements determine market access in the EU and the U.S.
Pesticide law reforms in Brazil and proposed reforms in India change registration timelines and compliance obligations.
Chemical safety and environmental laws govern siting and operation of intermediate plants.
Profiles of 104 companies operating in the Pyrethroid Intermediates Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
Meghmani Organics Limited is an Ahmedabad-based, export-led, backward-integrated specialty and agro-chemicals manufacturer controlled by the second generation of the Patel–Soparkar founding families. Its economic engine is Crop Protection (~78% of FY26 standalone revenue), where it is among India's top-10 pesticide manufacturers, spanning intermediates, technicals and 40+ branded formulations, with a pyrethroid and 2,4-D herbicide franchise sold into Brazil, the US, Africa, Latin America and Europe. Its second pillar, Pigments (~22%), positions it among the top three global phthalocyanine pigment producers with an ~8% share and the largest CPC-blue producer. Two adjacencies — liquid nano-fertilisers (Meghmani Crop Nutrition) and titanium dioxide (Kilburn Chemicals, currently suspended) — represent its diversification bets, both being folded into the parent through a pending amalgamation. About 85% of revenue is exported to 75+ countries. The investment case today is a margin-recovery and deleveraging story in a cyclical, tariff-exposed industry. --- ### Company's own description In its latest disclosures (Q4 FY26 press release, 14 May 2026; Q1 FY27 press release, 29 July 2026), the company describes itself as "a fully integrated diversified chemical company with presence in Crop Protection, Crop Nutrition and Pigments." It states that it is amongst the top three global phthalocyanine-based pigment players with an 8% market share and amongst the top-10 manufacturers of pesticides in India with a presence across the entire value chain; that it has 40+ brands of pesticide formulations in India and a 400+ customer base across diverse industries; that it has a global presence in 75+ countries with a distribution network of 3,500+ distributors and dealers across India; and that ~85% of its topline comes from export markets (FY26). ### What the company does — independent characterisation MOL is fundamentally a B2B batch-chemistry manufacturer whose competitive identity rests on three attributes: 1. **Backward integration.** In agrochemicals it produces key pyrethroid intermediates in-house — cypermethric acid chloride (CMAC), meta-phenoxy benzaldehyde (MPBD) and meta-phenoxy benzyl alcohol (MPBAL) — which CRISIL (Apr 2026) credits with reducing import dependence and conferring a cost advantage. In pigments it is backward-integrated into crude copper phthalocyanine (CPC) blue, the base for Pigment Blue 15-series and Pigment Green 7/36. 2. **Off-patent, generic-molecule exposure.** The crop-protection portfolio is predominantly mature generic molecules (synthetic pyrethroid insecticides, 2,4-D herbicide) sold as technicals to global formulators/distributors and as branded formulations domestically. Value creation therefore depends on registrations (788 product registrations in FY25 vs 693 in FY23, per company disclosures summarised by Screener), cost position and capacity utilisation, rather than proprietary IP. 3. **Export dependence.** ~85% export share (FY26) versus ~80% (FY24) makes MOL highly exposed to US tariffs, Brazilian demand cycles, Chinese pricing and global channel inventory cycles. Management has historically noted that ~45% of crop-protection demand comes from the US and Brazil (investor presentations, Nov 2023 and May 2024).
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
3 interactive charts drawn from the Pyrethroid Intermediates Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Pyrethroid Intermediates Market By Purity
Global Pyrethroid Intermediates Market By Downstream Product
Global Pyrethroid Intermediates Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)